Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Aug 7, 2007

30339_dirs_2007-08-07_e5e09ce4-af74-496a-b3c7-26bceecf8014.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-08-06

Reporting Person: BRITELL JENNE K (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-08-06 Common Stock M 2700 $24.4600 Acquired 4800.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-08-06 Stock Option (Right to Buy) $24.4600 M 2700 Disposed 2015-12-13 Common Stock (2700.0000) Direct